Outcome for children treated for relapsed or refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) consortium study

Authors

MF Gorman
L Ji
RH Ko
P Barnette
B Bostrom

Document Type

Journal Article

Publication Date

2010

Journal

Pediatric Blood and Cancer

Volume

55

Issue

3

Inclusive Pages

421-429

APA Citation

Gorman, M., Ji, L., Ko, R., Barnette, P., & Bostrom, B. (2010). Outcome for children treated for relapsed or refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) consortium study. Pediatric Blood and Cancer, 55 (3). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/5217